NEXT Oncology is a clinical research site located in Fairfax, Virginia, United States 22031.
Crixeo Clinical Trials Trust Score: 84/100 (GOOD). This profile has not yet been claimed by the site owner.
NEXT Oncology has participated in 37 clinical trials with 30 currently active.
Therapeutic areas: Gastric or Gastroesophageal Junction Adenocarcinoma, Pancreatic Ductal Adenocarcinoma, Biliary Tract Cancer (BTC).
Sponsors: Phanes Therapeutics, Janssen Research & Development, LLC, SystImmune Inc..
Trust Score: 84/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
NEXT Oncology has a Crixeo Trust Score of 84/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
NEXT Oncology has 37 clinical trials on record, with 30 currently active. Their work covers Gastric or Gastroesophageal Junction Adenocarcinoma, Pancreatic Ductal Adenocarcinoma, Biliary Tract Cancer (BTC).
NEXT Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.